Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial
Andreas J. Flammer(Zurich Heart House), Rachel Weber(University Hospital Zurich), Frank Ruschitzka(Kantonsspital St. Gallen), Martin Hersberger(University Children's Hospital Zurich), G. Noll(University Hospital Zurich), Andrea Gämperli(University Hospital Zurich), Angela Huttner(University Hospital of Geneva), Isabella Sudano(University Hospital Zurich), Iris Baumgärtner(Hirslanden Klinik Beau-Site), Matthias Hermann(Zurich Heart House), Daniel Hayoz(Fribourg Development Agency), Bruno Ledergerber(University Hospital of Zurich), N T T Vo(University Hospital Zurich), J. Evison(University Hospital of Bern), Kurt Quitzau(University Hospital Zurich), Thomas F. Lüscher(University of Zurich), Matthias Cavassini(University of Zurich)
Cited by 44
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k